TrialBlood2015

Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib.

Clare Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.